160 related articles for article (PubMed ID: 28890884)
1. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA
Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients.
Rashed RA; Hassan NM; Hussein MM
Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234
[TBL] [Abstract][Full Text] [Related]
5. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
9. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
10.
Su XY; Zhao Q; Ke JM; Wu DH; Zhu X; Lin J; Deng ZQ
Cancer Manag Res; 2020; 12():11871-11881. PubMed ID: 33239917
[TBL] [Abstract][Full Text] [Related]
11. [Expression and Clinical Significance of Serum MiR-370 and MiR-203 in Patients with Acute Myeloid Leukemia].
Ye LH; Ma X; Xu SC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):445-449. PubMed ID: 33812413
[TBL] [Abstract][Full Text] [Related]
12. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.
Ohyashiki JH; Umezu T; Kobayashi C; Hamamura RS; Tanaka M; Kuroda M; Ohyashiki K
BMC Res Notes; 2010 Dec; 3():347. PubMed ID: 21182798
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia.
Hong Z; Zhang R; Qi H
Cancer Biomark; 2018 Feb; 21(2):269-275. PubMed ID: 29226854
[TBL] [Abstract][Full Text] [Related]
14. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial microparticles and
Zhang Y; Cheng J; Chen F; Wu C; Zhang J; Ren X; Pan Y; Nie B; Li Q; Li Y
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28213360
[TBL] [Abstract][Full Text] [Related]
16. Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.
Wang X; Zhi X; Zhang Y; An G; Feng G
J Thorac Dis; 2016 Jul; 8(7):1645-52. PubMed ID: 27499953
[TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
18. Aspirin resistance may be identified by miR-92a in plasma combined with platelet distribution width.
Binderup HG; Houlind K; Madsen JS; Brasen CL
Clin Biochem; 2016 Oct; 49(15):1167-1172. PubMed ID: 27208561
[TBL] [Abstract][Full Text] [Related]
19. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y
BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
